A Follow-up Magnetic Resonance Imaging Study of Schizophrenia: Relationship of Neuroanatomical Changes to Clinical and Neurobehavioral Measures

Gur, Raquel E., Cowell, Patricia, Turetsky, Bruce I., Gallacher, Fiona, Cannon, Tyrone, Bilker, Warren, Gur, Ruben C.·1998·Archives of General Psychiatry

Cited by (540)

Items 201–300 of 540

  1. Antipsychotic Drugs for First-Episode Schizophrenia
    Kayvon Salimi, L. Fredrik Jarskog, Jeffrey Alan Lieberman · 2009 · CNS Drugs
  2. Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients
    Alexandra B. Whitworth, Georg Kemmler, Michaela Honeder, Christian Kremser, Stefan Felber, Armand Hausmann, Thomas Walch, Caroline Wanko, Elisabeth M. Weiss, C. Stuppaeck et al. · 2005 · Psychiatry Research Neuroimaging
  3. Schizophrenia in Late Life: Findings Challenge Traditional Concepts
    Barton W. Palmer, Fauzia Simjee McClure, Dilip V. Jeste · 2001 · Harvard Review of Psychiatry
  4. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: A preliminary report
    Tsutomu Takahashi, Michio Suzuki, Ryoichiro Tanino, Shi-Yu Zhou, Hirofumi Hagino, Lisha Niu, Yasuhiro Kawasaki, Hikaru Seto, Masayoshi Kurachi · 2007 · Psychiatry Research Neuroimaging
  5. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure
    Juan Bustillo, John Lauriello, Laura M. Rowland, Leigh Thomson, Helen Petropoulos, Rebecca Hammond, B HART, William Miles Brooks · 2002 · Schizophrenia Research
  6. The potential role of lamotrigine in schizophrenia
    Large, Charles H., Webster, Elizabeth L., Goff, Donald C. · 2005 · Psychopharmacology
  7. A Systematic and Meta-analytic Review of Neural Correlates of Functional Outcome in Schizophrenia
    Jessica A. Wojtalik, Matthew J. Smith, Matcheri S. Keshavan, Shaun M. Eack · 2017 · Schizophrenia Bulletin
  8. Neurobiology of early psychosis
    Matcheri S. Keshavan, Gregor Emanuel Berger, Robert B. Zipursky, Christos Pantelis, Stephen James Wood, Christos Pantelis · 2005 · The British Journal of Psychiatry
  9. Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study
    Gregor Emanuel Berger, Stephen James Wood, Margaret Ross, Clare Hamer, R. Mark Wellard, Gaby S. Pell, Lisa Phillips, Barnaby Nelson, G. Paul Amminger, Alison Ruth Yung et al. · 2012 · Current Pharmaceutical Design
  10. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment
    Mohamed Rifaat Ahmed, Dara M. Cannon, Cathy Scanlon, Laurena Holleran, Heike Anderson‐Schmidt, John W. Mcfarland, Camilla Langan, Peter McCarthy, Gareth J. Barker, Brian P. Hallahan et al. · 2015 · Neuropsychopharmacology
  11. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia
    Luisa Tomelleri, Jigar Jogia, Cinzia Perlini, Marcella Bellani, Adele Ferro, Gianluca Rambaldelli, Michele Tansella, Sophia Frangou, Paolo Brambilla · 2009 · European Neuropsychopharmacology
  12. Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
    L. Fredrik Jarskog, Zhengchao Dong, Alayar Kangarlu, Tiziano Colibazzi, Ragy R. Girgis, Lawrence S. Kegeles, Deanna M. Barch, Robert W. Buchanan, John G. Csernansky, DONALD C. GOFF et al. · 2013 · Neuropsychopharmacology
  13. Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study
    Gianfranco Spalletta, Francesco Tomaiuolo, Vittorio Marino, Giuseppina Bonaviri, Alberto Trequattrini, Carlo Caltagirone · 2003 · Schizophrenia Research
  14. Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America.
    Springer · 2011 · Ethical Human Psychology and Psychiatry
  15. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia
    N.M.J. van Veelen, Matthijs Vink, Nick F. Ramsey, René S. Kahn · 2010 · Schizophrenia Research
  16. Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment
    Bryan T. Woods, Kimberley Elaine Ward, Edwin H. Johnson · 2004 · Schizophrenia Research
  17. Evidence for Progression of Brain Structural Abnormalities in Schizophrenia: Beyond the Neurodevelopmental Model
    Dennis Velakoulis, Stephen James Wood, Patrick D. McGorry, Christos Pantelis · 2000 · Australian & New Zealand Journal of Psychiatry
  18. Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
    Brendan R. E. Ansell, Dominic Dwyer, Stephen James Wood, Emre Bora, Warrick J. Brewer, Tina Proffitt, Dennis Velakoulis, Patrick D. McGorry, Christos Pantelis · 2014 · Psychological Medicine
  19. Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia.
    Eugene Ruby, Stephanie Polito, Kevin L. McMahon, Marisa Gorovitz, Cheryl Mary Corcoran, Dolores Malaspina · 2014 · PubMed
  20. Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
    Amr Ellaithy, Jason Younkin, Javier González‐Maeso, Diomedes E. Logothetis · 2015 · Trends in Neurosciences
  21. Complementary and Alternative Medicine (CAM)
    Marlene P. Freeman · 2009 · The Journal of Clinical Psychiatry
  22. Brain volume, asymmetry and intellectual impairment in relation to sex in early-onset schizophrenia
    Simon L. Collinson, Clare E. Mackay, Anthony C. James, Digby J. Quested, Tania Phillips, Neil Roberts, Timothy John Crow · 2003 · The British Journal of Psychiatry
  23. The research evidence for schizophrenia as a neurodevelopmental disorder
    Bjørn Rishovd Rund · 2018 · Scandinavian Journal of Psychology
  24. Somal size of prefrontal cortical pyramidal neurons in schizophrenia
    Joseph N. Pierri, Christine L. E. Volk, Sungyoung Auh, Allan R. Sampson, David A. Lewis · 2003 · Biological Psychiatry
  25. The medial temporal lobe in schizophrenia
    Steven Edward Arnold · 1997 · Journal of Neuropsychiatry
  26. An fMRI Study of Episodic Encoding and Recognition of Words in Patients With Schizophrenia in Remission
    Alex Hofer, Elisabeth M. Weiss, Stefan Martin Golaszewski, Christian Siedentopf, Claudia Brinkhoff, Christian Kremser, Stephan R Felber, W. Wolfgang Fleischhacker · 2003 · American Journal of Psychiatry
  27. Influence of early trauma on features of schizophrenia
    Eugene Ruby, Karen Rothman, Cheryl Mary Corcoran, Raymond R. Goetz, Dolores Malaspina · 2015 · Early Intervention in Psychiatry
  28. Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study
    Maristela S. Schaufelberger, Julia Lappin, Fábio Duran, Pedro G. P. Rosa, Ricardo Riyoiti Uchida, L. C. Santos, Robin M. Murray, Philip K. McGuire, Márcia Scazufca, Paulo Rossi Menezes et al. · 2010 · Psychological Medicine
  29. A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia
    Michelle Deng, Grainne Mary McAlonan, Charlton Cheung, Cindy P.Y. Chiu, Chi Wing Law, Vinci Cheung, Pak Chung Sham, Eric Yu Hai Chen, Siew Eng Chua · 2009 · Psychopharmacology
  30. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment
    Siew Eng Chua, Yi Ming Deng, Eric Yu Hai Chen, Chi Wing Law, Cindy P.Y. Chiu, Chi Chun Garvin Cheung, Jason C.H. Wong, Nina Lienenkaemper, V. Cheung, John Suckling A et al. · 2008 · Psychological Medicine
  31. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia
    N.M.J. van Veelen, Matthijs Vink, Nick F. Ramsey, Mariët van Buuren, Janna Marie Bas‐Hoogendam, René S. Kahn · 2011 · Schizophrenia Research
  32. Brain Volume Changes After Withdrawal of Atypical Antipsychotics in Patients With First-Episode Schizophrenia
    Geartsje Boonstra, Neeltje E.M. van Haren, Hugo Gerard Schnack, Wiepke Cahn, Huibert Burger, Maria Boersma, Bart de Kroon, Diederick E. Grobbee, Hilleke E. Hulshoff Pol, René S. Kahn · 2011 · Journal of Clinical Psychopharmacology
  33. A systematic review of the structural neuroimaging correlates of thought disorder
    Philip J. Sumner, Imogen H. Bell, Susan Lee Rossell · 2017 · Neuroscience & Biobehavioral Reviews
  34. Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia
    Juan Bustillo, John Lauriello, Laura M. Rowland, Rex Eugene Jung, Helen Petropoulos, Blaine L. Hart, Jack J. Blanchard, Samuel J. Keith, William Miles Brooks · 2001 · Psychiatry Research Neuroimaging
  35. Regional brain volume change over the life-time course of schizophrenia
    Lynn E. DeLisi · 1999 · Journal of Psychiatric Research
  36. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration
    Vicente Molina, Javier Cabello Sánchez, Santiago Reig, Javier Sanz, Carlos Benito C, Cristina Santa-Marta, Javier Pascau, Fernando Sarramea, Juan Domingo Gispert, José M. Misiego et al. · 2004 · Schizophrenia Research
  37. Childhood-Onset Schizophrenia: Insights From Neuroimaging Studies
    Andrew J. Gerber, Bradley S. Peterson, Nitin Gogtay, Judith L. Rapoport · 2008 · Journal of the American Academy of Child & Adolescent Psychiatry
  38. Gray matter volume differences specific to formal thought disorder in schizophrenia
    Helge Horn, Andrea Federspiel, Miranka Wirth, Thomas Müller, Roland Wiest, Sebastian Walther, Werner Konrad Strik · 2010 · Psychiatry Research Neuroimaging
  39. Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study
    Tomoyuki Saijo, Tetsuo Abe, Yasuhiro Someya, Takeshi Sassa, Yasuhiko Sudo, Tetsuya Suhara, Takehiko Shuno, Kunihiko Asai, Yoshiro Okubo · 2001 · Psychiatry and Clinical Neurosciences
  40. Cerebral metabolic patterns in chronic and recent-onset schizophrenia
    Manuel Desco, Juan Domingo Gispert, Santiago Reig, Javier Sanz, Javier Pascau, Fernando Sarramea, Carlos Benito C, Andrés Santos, Tomás Palomo, Vicente Molina · 2003 · Psychiatry Research Neuroimaging
  41. Hospitalization and psychosis: Influences on the course of cognition and everyday functioning in people with schizophrenia
    Philip D. Harvey, David Loewenstein, Sara J. Czaja · 2012 · Neurobiology of Disease
  42. Could Stress Cause Psychosis in Individuals Vulnerable to Schizophrenia?
    Cheryl Mary Corcoran, Lilianne Rivka Mujica-Parodi, Scott A. Yale, David Leitman, Dolores Malaspina · 2002 · CNS Spectrums
  43. Neuroprogression across the Early Course of Psychosis
    Kathryn E. Lewandowski, Sylvain Bouix A, Döst Öngür, Martha Elizabeth Shenton · 2020 · Journal of Psychiatry and Brain Science
  44. Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System
    Oliver Gruber, Antonella Santuccione Chadha, Helmut Aach · 2014 · Frontiers in Psychiatry
  45. Effect of antipsychotic drugs on brain morphometry.
    Benedicto Crespo‐Facorro, Roberto Roiz‐Santiáñez, Rocío Pérez‐Iglesias, José María Pelayo‐Terán, José Manuel Rodríguez-Sánchez, Diana Tordesillas‐Gutiérrez, María Luz Ramírez, Obdulia Martínez, Agustín Gutiérrez, Enrique Marco de Lucas et al. · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  46. Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N‐acetylaspartate and frontal lobe dysfunction
    Yoko Tanaka, Takayuki Obata, TAKESHI SASSA, Eiji Yoshitome, Yoshiyuki Asai, Hiroo Ikehira, Tetsuya Suhara, Yoshiro Okubo, Toru Nishikawa · 2006 · Psychiatry and Clinical Neurosciences
  47. Analysis of cross-correlations in electroencephalogram signals as an approach to proactive diagnosis of schizophrenia
    С. Ф. Тимашев, Oleg Panischev, Yuriy Polyakov, Дёмин Сергей Анатольевич, Alexander Kaplan · 2011 · Physica A Statistical Mechanics and its Applications
  48. Longitudinal Assessment of Gray and White Matter in Chronic Schizophrenia: A Combined Diffusion-Tensor and Structural Magnetic Resonance Imaging Study
    Serge A. Mitelman, Emily L. Canfield, Randall E. Newmark, Adam M. Brickman, Yuliya Torosjan, King-Wai Chu, Erin A. Hazlett, M. Mehmet Haznedar, Lina Shihabuddin, Monte S. Buchsbaum · 2009 · The Open Neuroimaging Journal
  49. The Structural Neural Substrates of Persistent Negative Symptoms in First-Episode of Non-Affective Psychosis: A Voxel-Based Morphometry Study
    Audrey Benoit, Michael D. Bodnar, ASHOK K. MALLA, Ridha Joober, Martín Lepage · 2012 · Frontiers in Psychiatry
  50. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence
    Berend Malchow, Alkomiet Hasan, Paolo Fusar‐Poli, Andrea Schmitt, Peter Falkai, Thomas Wobrock · 2012 · European Archives of Psychiatry and Clinical Neuroscience
  51. Cortical surface characteristics among offspring of schizophrenia subjects
    Konasale M. R. Prasad, Dhruman D. Goradia, Shaun M. Eack, Malolan Sri Rajagopalan, Jeffrey J. Nutche, Tara Magge, Rajaprabhakaran Rajarethinam, Matcheri S. Keshavan · 2009 · Schizophrenia Research
  52. Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review
    Roberto Roiz‐Santiáñez, Paula Suárez‐Pinilla, Benedicto Crespo‐Facorro · 2015 · Current Neuropharmacology
  53. Frontale Hirnvolumenminderung durch Antipsychotika?
    Volkmar Aderhold, Stefan Weinmann, Claudia Hägele, Andreas Heinz · 2014 · Der Nervenarzt
  54. Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study
    Tsutomu Takahashi, Michio Suzuki, Yasuhiro Kawasaki, Hirofumi Hagino, Ikiko Yamashita, Shigeru Nohara, Kazue Nakamura, Hikaru Seto, Masayoshi Kurachi · 2003 · Biological Psychiatry
  55. The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states
    Patricia Westmoreland Corson, Daniel S. OʼLeary, Del D. Miller, Nancy C. Andreasen · 2002 · Biological Psychiatry
  56. Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: A population-based study of first-episode psychosis
    Taís Michele Minatogawa, Maristela S. Schaufelberger, Adriana M. Ayres, Fábio Duran, Elisa Kijner Gutt, Robin M. Murray, Teresa Rushe, Philip K. McGuire, Paulo Rossi Menezes, Márcia Scazufca et al. · 2009 · Schizophrenia Research
  57. S100B in schizophrenia: an update.
    Matthias Rothermundt, Jan Niklas Ahn, Silke Jörgens · 2009 · PubMed
  58. Progression of Brain Volume Changes in Adolescent-Onset Psychosis
    Santiago Reig, Carmen Moreno, Dolores Maria Moreno, M.T. Burdalo, Joost Janssen, Mara Parellada, Arantzazu Zabala, Manuel Desco, Celso Arango · 2008 · Schizophrenia Bulletin
  59. Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients
    Vicente Molina, Javier Sanz, Fernando Sarramea, Carlos Benito C, Tomás Palomo · 2004 · Psychiatry Research Neuroimaging
  60. Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry
    Daniel H. Mathalon, Judith L. Rapoport, Kenneth L. Davis, John Harrison Krystal · 2003 · Archives of General Psychiatry
  61. Volumetric MRI study of the short and long insular cortices in schizophrenia spectrum disorders
    Tsutomu Takahashi, Michio Suzuki, Shi-Yu Zhou, Hirofumi Hagino, Ryoichiro Tanino, Yasuhiro Kawasaki, Shigeru Nohara, Ikiko Yamashita, Hikaru Seto, Masayoshi Kurachi · 2005 · Psychiatry Research Neuroimaging
  62. Neuropsychological Profile and Neuroimaging in Patients with 22Q11.2 Deletion Syndrome: A Review Keywords:
    Janneke Zinkstok, Thérèse van Amelsvoort · 2005 · Child Neuropsychology
  63. Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes
    Julia Lappin, Craig Morgan, Sima Chalavi, Kevin D Morgan, Antje A. T. S. Reinders, P. Fearon, Margaret Heslin, Jolanta Zanelli, Peter Brian Jones, Robin M. Murray et al. · 2013 · Psychological Medicine
  64. Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques.
    Claudia Mehler, Andreas Warnke · 2002 · Journal of Neural Transmission
  65. Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder*1
    Keith L. Davis · 2004 · Journal of Affective Disorders
  66. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia
    Preethi Premkumar, Dominic G. Fannon, Elizabeth Kuipers, Michael A. Cooke, Andrew Simmons, Veena Kumari · 2008 · Behavioural Brain Research
  67. Childhood-Onset Schizophrenia: Research Update
    Sanjiv Kumra, Maryanne Shaw, Patricia Merka, Emilie Y. Nakayama, Rachel Augustin · 2001 · The Canadian Journal of Psychiatry
  68. Size of hippocampal pyramidal neurons in schizophrenia
    J. Robin Highley, Mary A. Walker, B. McDonald, Timothy John Crow, Margaret M. Esiri · 2003 · The British Journal of Psychiatry
  69. Increases in Regional Subarachnoid CSF Without Apparent Cortical Gray Matter Deficits in Schizophrenia: Modulating Effects of Sex and Age
    Katherine L. Narr, Tonmoy Sharma, Roger P. Woods, Paul M. Thompson, Elizabeth R. Sowell, D Rex, Sharon H. Kim, Dina M. Asuncion, Seonah Jang, John C. Mazziotta et al. · 2003 · American Journal of Psychiatry
  70. Comorbid substance abuse and brain morphology in recent-onset psychosis
    Thomas Wobrock, Helmut Sittinger, Bernd Behrendt, Roberto D’Amelio, Peter Falkai · 2009 · European Archives of Psychiatry and Clinical Neuroscience
  71. Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: Differential sensitivity of clinical neuropsychological and experimental information processing tests
    Christopher R. Bowie, Abraham Reichenberg, Margaret McNamara McClure, Winnie L. Leung, Philip D. Harvey · 2007 · Schizophrenia Research
  72. Caspase-3 Activation in Rat Frontal Cortex Following Treatment with Typical and Atypical Antipsychotics
    L. Fredrik Jarskog, John H. Gilmore, Leisa A. Glantz, Karissa Gable, Thomas T. German, Ruth I Tong, Jeffrey Alan Lieberman · 2006 · Neuropsychopharmacology
  73. Progressive Reduction of Visual P300 Amplitude in Patients With First-Episode Schizophrenia: An ERP Study
    Naoya Oribe, Yoji Hirano, Shigenobu Kanba, Elisabetta C. del Re, Larry J. Seidman, R I Mesholam-Gately, Jill M. Goldstein, Martha Elizabeth Shenton, K Spencer, Robert W. McCarley et al. · 2014 · Schizophrenia Bulletin
  74. Brain and ventricle instability during psychotic episodes of the schizophrenias
    D. Garver, Thamilarasi R. Nair, J.D Christensen, Jennifer A. Holcomb, S Kingsbury · 2000 · Schizophrenia Research
  75. An In Vivo MRI Study of Prefrontal Cortical Complexity in First-Episode Psychosis
    Laura C. Wiegand, Simon Keith Warfield, James Jonathan Levitt, Yoshio Hirayasu, Dean F. Salisbury, Stephan Heckers, Sylvain Bouix A, Daniel Schwartz, Magdalena H. Spencer, Chandlee C. Dickey et al. · 2004 · American Journal of Psychiatry
  76. P300 amplitude as a possible correlate of frontal degeneration in schizophrenia
    Martı́n-Loeches, Manuel, Molina, Vicente, Muñoz, Francisco, Hinojosa, José A., Reig, Santiago, Desco, Manuel, Benito, C., Sanz, Javier, Gabiri, Ainhoa, Sarramea, Fernando et al. · 2001 · Schizophrenia Research
  77. At issue: stress, hippocampal neuronal turnover, and neuropsychiatric disorders
    Arango, C., Kirkpatrick, B., Koenig, J. · 2001 · Schizophrenia Bulletin
  78. Neurodegeneration in Schizophrenia: Evidence fromIn VivoNeuroimaging Studies
    John G. Csernansky · 2007 · The Scientific World JOURNAL
  79. Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics
    Vicente Molina, Santiago Reig, Javier Sanz, Tomás Palomo, C. Benito, Fernando Sarramea, Javier Pascau, Javier Cabello Sánchez, Manuel Martín‐Loeches, Francisco Muñoz et al. · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  80. Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry
    Vicente Molina, Gemma Galindo, Benjamín Cortés, Alba García Seco de Herrera, Ana Ledo, Javier Sanz, Carlos Montes, Juan Antonio Hernandez-Tamames · 2010 · European Archives of Psychiatry and Clinical Neuroscience
  81. Biomarkers for Psychiatric Disorders
    Christoph W. Turck · 2009 · Springer eBooks
  82. Reduced frontal slow wave density during sleep in first-episode psychosis
    Rachel E. Kaskie, Kathryn M. Gill, Fabio Ferrarelli · 2018 · Schizophrenia Research
  83. Does schizophrenia result from developmental or degenerative processes?
    S. M. Church, David Cotter, Elvira Bramon, Robin M. Murray · 2002 · Springer eBooks
  84. Long-term effects of the maternal deprivation on the volume and number of neurons in the rat neocortex and hippocampus
    Milan Aksić, Nevena V. Radonjić, Dubravka Aleksić, G. Jevtić, Branka Marković, Nataša Petronijević, Vidosava Radonjić, Branislav Filipović · 2013 · Acta Neurobiologiae Experimentalis
  85. Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia
    Ruth A. Spinks, Peg Nopoulos, Julie Ward, Rebecca L. M. Fuller, Vincent A. Magnotta, Nancy C. Andreasen · 2004 · Schizophrenia Research
  86. Prefrontal Structural and Functional Deficits in Schizotypal Personality Disorder
    Adrian Raine, Todd Lencz, Pauline Yaralian, Susan Bihrle, Lena Ribas Lacasse, Joseph Ventura, Patrick M. Colletti · 2002 · Schizophrenia Bulletin
  87. Hypofrontality in men with first-episode psychosis
    Vicente Molina, Javier Sanz, Santiago Reig, R. Martínez, Fernando Sarramea, R. Luque, C. Benito, Juan Domingo Gispert, Javier Pascau, Manuel Desco · 2005 · The British Journal of Psychiatry
  88. Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
    Davide Amato, Clare L. Beasley, Margaret Hahn, Anthony Christopher Vernon · 2016 · Neuroscience & Biobehavioral Reviews
  89. Structural Neuroimaging in Adolescents With a First Psychotic Episode
    Dolores Maria Moreno, M.T. Burdalo, Santiago Reig, Mara Parellada, Arantzazu Zabala, Manuel Desco, Enrique Baca‐Baldomero, Celso Arango · 2005 · Journal of the American Academy of Child & Adolescent Psychiatry
  90. Volumetric magnetic resonance imaging study of the anterior cingulate gyrus in schizotypal disorder
    Tsutomu Takahashi, Michio Suzuki, Yasuhiro Kawasaki, Kenzo Kurokawa, Hirofumi Hagino, Ikiko Yamashita, Shi-Yu Zhou, Shigeru Nohara, Kazue Nakamura, Hikaru Seto et al. · 2002 · European Archives of Psychiatry and Clinical Neuroscience
  91. Smaller Neocortical Gray Matter and Larger Sulcal Cerebrospinal Fluid Volumes in Neuroleptic-Naive Women With Schizotypal Personality Disorder
    Min‐Seong Koo, Chandlee C. Dickey, Hae‐Jeong Park, Marek R. Kubicki, Na Young Ji, Sylvain Bouix A, Kilian M. Pohl, James Jonathan Levitt, Motoaki Nakamura, Martha Elizabeth Shenton et al. · 2006 · Archives of General Psychiatry
  92. Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque
    Lynn D. Selemon, Lei Wang, Mary Beth Nebel, John G. Csernansky, Patricia S. Goldman, PASKO T. RAKIC · 2004 · Biological Psychiatry
  93. Prenatal Factors and Adult Mental and Physical Health
    Ezra Susser, Alan S. Brown, Thomas Matte · 1999 · The Canadian Journal of Psychiatry
  94. Multicenter Study of Brain Volume Abnormalities in Children and Adolescent-Onset Psychosis
    Santiago Reig, Mara Parellada, Josefina Castro‐Fornieles, Joost Janssen, Dolores Maria Moreno, Inmaculada Baeza, Núria Bargalló, Ana María González-Pinto, Montserrat Graell, F. Ortuno et al. · 2010 · Schizophrenia Bulletin
  95. The Relationship of Developmental Changes in White Matter to the Onset of Psychosis
    Katherine H. Karlsgodt, Sarah C. Jacobson, Marc L. Seal, Paolo Fusar‐Poli · 2012 · Current Pharmaceutical Design
  96. An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium
    Ting Yat Wong, Joaquim Raduà, Edith Pomarol‐Clotet, Raymond M. Salvador, Anton Albajes‐Eizagirre, Aleix Solanes, Erick Jorge Canales-Rodríguez, Amalia Guerrero‐Pedraza, Salvador Sarró, Tilo T. J. Kircher et al. · 2019 · Psychological Medicine
  97. Cerebral atrophy and white matter disruption in chronic schizophrenia
    Nicola Andreone, Michele Tansella, Roberto Cerini, Gianluca Rambaldelli, Amelia Versace, Giovanna Marrella, Cinzia Perlini, Nicola Dusi, Luisa Pelizza, Matteo Balestrieri et al. · 2006 · European Archives of Psychiatry and Clinical Neuroscience
  98. Globally and Locally Reduced MRI Gray Matter Volumes in Neuroleptic-Naive Men With Schizotypal Personality Disorder
    Takeshi Asami, Thomas J. Whitford, Sylvain Bouix A, Chandlee C. Dickey, Margaret A. Niznikiewicz, Martha Elizabeth Shenton, Martina M. Voglmaier, Robert W. McCarley · 2013 · JAMA Psychiatry
  99. Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project
    Heather Clare Whalley, Julia N. Kestelman, J E Rimmington, Andrew R. C. Kelso, Suheib S. Abukmeil, Jonathan J.K. Best, Eve C. Johnstone, Stephen M. Lawrie · 1999 · Psychiatry Research Neuroimaging
  100. The course of brain abnormalities in schizophrenia: can we slow the progression?
    Neeltje E.M. van Haren, Wiepke Cahn, Hilleke E. Hulshoff Pol, René S. Kahn · 2011 · Journal of Psychopharmacology